Privia Health Group (NASDAQ:PRVA) Given Overweight Rating at Stephens

Privia Health Group (NASDAQ:PRVA)‘s stock had its “overweight” rating reissued by equities researchers at Stephens in a note issued to investors on Thursday,Benzinga reports. They currently have a $32.00 price target on the stock. Stephens’ price objective suggests a potential upside of 32.24% from the stock’s current price.

PRVA has been the subject of several other research reports. Barclays increased their price target on shares of Privia Health Group from $22.00 to $23.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. Evercore ISI lifted their price target on shares of Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Canaccord Genuity Group boosted their price target on shares of Privia Health Group from $32.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, November 12th. Citigroup restated an “outperform” rating on shares of Privia Health Group in a report on Friday, August 29th. Finally, Citizens Jmp lifted their target price on shares of Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a report on Friday, November 7th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Privia Health Group presently has a consensus rating of “Moderate Buy” and an average price target of $30.00.

Privia Health Group Stock Performance

NASDAQ:PRVA opened at $24.20 on Thursday. Privia Health Group has a one year low of $18.77 and a one year high of $26.51. The stock has a market cap of $2.98 billion, a PE ratio of 186.36, a P/E/G ratio of 4.00 and a beta of 0.83. The stock has a 50 day moving average price of $24.46 and a 200 day moving average price of $22.77.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%.The company had revenue of $213.61 million during the quarter. As a group, analysts predict that Privia Health Group will post 0.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Privia Health Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PRVA. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Privia Health Group by 180.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,633,040 shares of the company’s stock worth $59,112,000 after acquiring an additional 1,693,870 shares in the last quarter. Nuveen LLC acquired a new position in Privia Health Group during the 1st quarter worth $26,899,000. Van Berkom & Associates Inc. grew its stake in Privia Health Group by 30.1% during the 3rd quarter. Van Berkom & Associates Inc. now owns 3,774,565 shares of the company’s stock worth $93,987,000 after purchasing an additional 873,344 shares in the last quarter. Vanguard Group Inc. raised its position in Privia Health Group by 5.3% in the 3rd quarter. Vanguard Group Inc. now owns 12,098,933 shares of the company’s stock valued at $301,263,000 after purchasing an additional 607,447 shares in the last quarter. Finally, Algert Global LLC raised its position in Privia Health Group by 277.4% in the 3rd quarter. Algert Global LLC now owns 484,304 shares of the company’s stock valued at $12,059,000 after purchasing an additional 355,966 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.